Source: FinanzNachrichten

Victoza: Victoza® lowered the progression of kidney damage in adults with type 2 diabetes at high CV risk

MUNICH, September 15, 2016 /PRNewswire/ -- This material is intended for global medical media only. For journalistic assessment and preparation before publication. Novo Nordisk today announced tha...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more